CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Selective Venography followed by therapeutic balloon angioplasty +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01450072
NCT01450072N/ACompleted
CompareCT.gov

Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE

State University of New York at Buffalo·interventional·Posted Oct 12, 2011·Updated Jun 18, 2025

In Brief

A clinical study evaluating Selective Venography followed by therapeutic balloon angioplasty and Control arm for Multiple Sclerosis. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The Departments of Neurology and Neurosurgery are conducting this research study to evaluate the safety and effectiveness of intravascular angioplasty for the treatment of venous narrowing in the treatment of Multiple Sclerosis (MS).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 12, 2011
Enrollment StartJun 1, 2010
Primary CompletionDec 1, 2011
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 14.7 years ago

Interventions

Selective Venography followed by therapeutic balloon angioplastydevice

Venography followed by therapeutic balloon angioplasty

Control armother

Venography and sham angioplasty